These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18591486)

  • 1. Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.
    Kim CH; Waldman ID; Blakely RD; Kim KS
    Ann N Y Acad Sci; 2008; 1129():256-60. PubMed ID: 18591486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
    Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
    Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.
    Kim CH; Hahn MK; Joung Y; Anderson SL; Steele AH; Mazei-Robinson MS; Gizer I; Teicher MH; Cohen BM; Robertson D; Waldman ID; Blakely RD; Kim KS
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19164-9. PubMed ID: 17146058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.
    Rippel CA; Kobets AJ; Yoon DY; Williams PN; Shugart YY; Bridges DD; Vandenbergh DJ; Singer HS
    Psychiatr Genet; 2006 Oct; 16(5):179-80. PubMed ID: 16969268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population.
    Joung Y; Kim CH; Moon J; Jang WS; Yang J; Shin D; Lee S; Kim KS
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):691-694. PubMed ID: 19685476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population.
    McEvoy B; Hawi Z; Fitzgerald M; Gill M
    Am J Med Genet; 2002 Aug; 114(6):665-6. PubMed ID: 12210284
    [No Abstract]   [Full Text] [Related]  

  • 7. Association analysis of serotonin transporter promoter gene polymorphism with ADHD and related symptomatology.
    Zhao AL; Su LY; Zhang YH; Tang BS; Luo XR; Huang CX; Su QR
    Int J Neurosci; 2005 Aug; 115(8):1183-91. PubMed ID: 16040360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.
    Shang CY; Chiang HL; Gau SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():89-96. PubMed ID: 25554436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
    Hahn MK; Steele A; Couch RS; Stein MA; Krueger JJ
    Neuropharmacology; 2009 Dec; 57(7-8):694-701. PubMed ID: 19698724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans.
    Reif A; Jacob CP; Rujescu D; Herterich S; Lang S; Gutknecht L; Baehne CG; Strobel A; Freitag CM; Giegling I; Romanos M; Hartmann A; Rösler M; Renner TJ; Fallgatter AJ; Retz W; Ehlis AC; Lesch KP
    Arch Gen Psychiatry; 2009 Jan; 66(1):41-50. PubMed ID: 19124687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
    Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of norepinephrine transporter (NET, SLC6A2) genotype with ADHD-related phenotypes: findings of a longitudinal study from birth to adolescence.
    Hohmann S; Hohm E; Treutlein J; Blomeyer D; Jennen-Steinmetz C; Schmidt MH; Esser G; Banaschewski T; Brandeis D; Laucht M
    Psychiatry Res; 2015 Apr; 226(2-3):425-33. PubMed ID: 25724484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association study between the norepinephrine transporter gene and depression.
    Buttenschøn HN; Jacobsen IS; Grynderup MB; Hansen AM; Kolstad HA; Kaerlev L; Thomsen JF; Nordentoft M; Silahtaroglu A; Tommerup N; Tümer Z; Krogh J; Børglum AD; Mors O
    Psychiatr Genet; 2013 Oct; 23(5):217-21. PubMed ID: 23969988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
    Retz W; Rösler M; Kissling C; Wiemann S; Hünnerkopf R; Coogan A; Thome J; Freitag C
    J Neural Transm (Vienna); 2008; 115(2):323-9. PubMed ID: 17994190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-based association study of ciliary neurotrophic factor receptor and norepinephrine transporter genes in attention-deficit hyperactivity disorder.
    Tzang RF; Hsu CD; Liou YJ; Hong CJ; Tsai SJ
    Psychiatr Genet; 2014 Jun; 24(3):118-9. PubMed ID: 24565995
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No causal role for the G482T and G689T polymorphisms in translation regulation of serotonin transporter (SLC6A4) or association with attention-deficit-hyperactivity disorder (ADHD).
    Banerjee E; Sinha S; Chatterjee A; Nandagopal K
    Neurosci Lett; 2009 May; 454(3):244-8. PubMed ID: 19429092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.